• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Intubation-Surfactant: Extubation on Continuous Positive Pressure Ventilation. Who are the Best Candidates?插管-表面活性剂:持续正压通气下拔管。最佳候选人是谁?
J Crit Care Med (Targu Mures). 2016 May 9;2(2):73-79. doi: 10.1515/jccm-2016-0010. eCollection 2016 Apr.
2
Efficacy of INSURE during nasal CPAP in preterm infants with respiratory distress syndrome.持续气道正压通气期间INSURE策略用于呼吸窘迫综合征早产儿的疗效
Minerva Pediatr. 2013 Apr;65(2):187-92.
3
Early nasal continuous positive airway pressure versus INSURE in VLBW neonates.极低出生体重儿早期经鼻持续气道正压通气与INSURE策略的比较
Rev Port Pneumol. 2010 Sep-Oct;16(5):779-95.
4
Is it feasible to identify preterm infants with respiratory distress syndrome for early extubation to continuous positive airway pressure post-surfactant treatment during retrieval?在转运过程中,对于接受表面活性剂治疗后的呼吸窘迫综合征早产儿,识别出适合早期拔管并给予持续气道正压通气的患儿是否可行?
J Paediatr Child Health. 2015 Mar;51(3):321-7. doi: 10.1111/jpc.12724. Epub 2014 Sep 5.
5
The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.表面活性剂给药技术(肺内滴注法与气管插管-肺表面活性物质给药法)对早产儿呼吸窘迫综合征治疗结局的影响。
Dev Period Med. 2019;23(3):163-171. doi: 10.34763/devperiodmed.20192303.163171.
6
7
Post-INSURE Administration of Heated Humidified High-Flow Therapy Versus Nasal Continuous Positive Airway Pressure in Preterm Infants More Than 28 Weeks Gestation with Respiratory Distress Syndrome: A Randomized Non-Inferiority Trial.28 周以上有呼吸窘迫综合征的早产儿经鼻持续气道正压通气与加热湿化高流量鼻导管吸氧序贯治疗的随机非劣效性试验。
J Trop Pediatr. 2022 Jun 6;68(4). doi: 10.1093/tropej/fmac062.
8
Comparison of the effect of surfactant administration during nasal continuous positive airway pressure with that of nasal continuous positive airway pressure alone on complications of respiratory distress syndrome: a randomized controlled study.经鼻持续气道正压通气时使用表面活性剂与单纯经鼻持续气道正压通气对呼吸窘迫综合征并发症影响的比较:一项随机对照研究。
Pediatr Neonatol. 2015 Apr;56(2):88-94. doi: 10.1016/j.pedneo.2014.05.006. Epub 2014 Sep 26.
9
Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study.预测经口气管插管-表面活性物质-拔管失败的因素:一项队列研究。
BMC Pediatr. 2014 Jun 19;14:155. doi: 10.1186/1471-2431-14-155.
10
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.对于患有呼吸窘迫综合征(RDS)或有RDS风险的早产儿,早期给予表面活性剂并进行短暂通气与选择性给予表面活性剂及持续机械通气的比较。
Cochrane Database Syst Rev. 2002(2):CD003063. doi: 10.1002/14651858.CD003063.

引用本文的文献

1
Persistent Ductus Arteriosus in Critically Ill Preterm Infants.危重新生儿持续性动脉导管未闭
J Crit Care Med (Targu Mures). 2016 Nov 8;2(4):175-184. doi: 10.1515/jccm-2016-0026. eCollection 2016 Oct.

本文引用的文献

1
Comparison of INSURE method with conventional mechanical ventilation after surfactant administration in preterm infants with respiratory distress syndrome: therapeutic challenge.表面活性物质给药后,INSURE方法与传统机械通气在呼吸窘迫综合征早产儿中的比较:治疗挑战
Acta Med Iran. 2014;52(8):596-600.
2
Predictors for an unsuccessful INtubation-SURfactant-Extubation procedure: a cohort study.预测经口气管插管-表面活性物质-拔管失败的因素:一项队列研究。
BMC Pediatr. 2014 Jun 19;14:155. doi: 10.1186/1471-2431-14-155.
3
[Risk factors for the failure of the InSure method in very preterm infants with respiratory distress syndrome].[因呼吸窘迫综合征导致的极早产儿使用InSure方法失败的危险因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2014 Jun;16(6):610-3.
4
European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update.欧洲早产儿呼吸窘迫综合征管理共识指南——2013 年更新版。
Neonatology. 2013;103(4):353-68. doi: 10.1159/000349928. Epub 2013 May 31.
5
Efficacy of INSURE during nasal CPAP in preterm infants with respiratory distress syndrome.持续气道正压通气期间INSURE策略用于呼吸窘迫综合征早产儿的疗效
Minerva Pediatr. 2013 Apr;65(2):187-92.
6
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.早期与延迟选择性表面活性剂治疗新生儿呼吸窘迫综合征
Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD001456. doi: 10.1002/14651858.CD001456.pub2.
7
The outcome of ELBW infants treated with NCPAP and InSurE in a resource-limited institution.资源有限机构中采用 NCPAP 和 InSurE 治疗极低出生体重儿的结局。
Pediatrics. 2012 Apr;129(4):e952-9. doi: 10.1542/peds.2011-1365. Epub 2012 Mar 19.
8
Part 15: neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.第15部分:新生儿复苏:2010年美国心脏协会心肺复苏及心血管急救指南
Circulation. 2010 Nov 2;122(18 Suppl 3):S909-19. doi: 10.1161/CIRCULATIONAHA.110.971119.
9
Prophylactic administration of surfactant in extremely premature infants.对极早产儿预防性给予表面活性剂。
Crit Care Res Pract. 2010;2010. doi: 10.1155/2010/235894. Epub 2010 Jun 7.
10
European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update.欧洲早产儿呼吸窘迫综合征管理共识指南-2010 年更新版。
Neonatology. 2010 Jun;97(4):402-17. doi: 10.1159/000297773. Epub 2010 Jun 10.

插管-表面活性剂:持续正压通气下拔管。最佳候选人是谁?

Intubation-Surfactant: Extubation on Continuous Positive Pressure Ventilation. Who are the Best Candidates?

作者信息

Ognean Maria Livia, Stoicescu Silvia-Maria, Boantă Oana, Năstase Leonard, Gliga Carmen, Cucerea Manuela

机构信息

Clinical County Emergency Hospital Sibiu, Neonatology Department, Sibiu, Romania.

University of Medicine and Pharmacy Carol Davila Bucuresti, Institute of Mother and Child Care - Polizu, Neonatology Department, Bucharest, Romania.

出版信息

J Crit Care Med (Targu Mures). 2016 May 9;2(2):73-79. doi: 10.1515/jccm-2016-0010. eCollection 2016 Apr.

DOI:10.1515/jccm-2016-0010
PMID:29967841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5939130/
Abstract

INTRODUCTION

Respiratory distress syndrome (RDS) continues to be the leading cause of illness and death in preterm infants. Studies indicate that INSURE strategy (INtubate-SURfactant administration and Extubate to nasal continuous positive airway pressure [nCPAP]) is better than mechanical ventilation (MV) with rescue surfactant, for the management of respiratory distress syndrome (RDS) in very low birth weight (VLBW) neonates, as it has a synergistic effect on alveolar stability.

AIM OF THE STUDY

To identify the factors associated with INSURE strategy failure in preterm infants with gestational age (GA) ≤ 32 weeks.

MATERIALS AND METHODS

This was a retrospective cohort study, based on data collected in the Romanian National Registry for RDS patients by three regional (level III) centers between 01.01.2010 and 31.12.2011. All preterm infants of ≤ 32 weeks GA were included. Prenatal and neonatal information were compared between (Group 1), the preterm infants successfully treated using INtubation-SURfactant-Extubation on nasal CPAP (INSURE) strategy and (Group 2 ), those who needed mechanical ventilation within seventy two hours after INSURE.

RESULTS

A total of 637 preterm infants with GA ≤ 32 weeks were included in the study. INSURE strategy was performed in fifty seven cases (8.9%) [ Group 1] and was successful in thirty one patients (54.4%). No differences were found as regards the studied prenatal and intranatal characteristics between (Group 1) and Group 2 who needed mechanical ventilation. Group 2 preterm infants who needed mechanical ventilation within 72 hours after INSURE had significantly lower mean Apgar scores at 1 and 5 minutes and lower peripheral oxygen saturation (SpO2) during resuscitation at birth (p<0.05). Successful INSURE strategy was associated with greater GA, birth weight (BW), fraction of inspired oxygen (FiO2) during resuscitation, and an increased mean dose of surfactant but these associations were not statistically significant (p>0.5).

CONCLUSION

In preterm infants ≤ 32 weeks gestation, increased INSURE failure rates are associated with complicated pregnancies, significantly lower Apgar scores at 1 and 5 minutes, and lower peripheral oxygen saturation during resuscitation.

摘要

引言

呼吸窘迫综合征(RDS)仍然是早产儿发病和死亡的主要原因。研究表明,INSURE策略(气管插管-表面活性剂给药并拔管至鼻持续气道正压通气[nCPAP])在极低出生体重(VLBW)新生儿呼吸窘迫综合征(RDS)的管理中优于机械通气(MV)联合挽救性表面活性剂治疗,因为它对肺泡稳定性具有协同作用。

研究目的

确定胎龄(GA)≤32周的早产儿中与INSURE策略失败相关的因素。

材料与方法

这是一项回顾性队列研究,基于罗马尼亚国家RDS患者登记处三个地区(三级)中心在2010年1月1日至2011年12月31日期间收集的数据。纳入所有GA≤32周的早产儿。比较了(第1组)使用气管插管-表面活性剂-拔管至鼻CPAP(INSURE)策略成功治疗的早产儿与(第2组)在INSURE后72小时内需要机械通气的早产儿的产前和新生儿信息。

结果

共有637例GA≤32周的早产儿纳入研究。57例(8.9%)实施了INSURE策略[第1组],其中31例(54.4%)成功。在(第1组)和需要机械通气的第2组之间,所研究的产前和产时特征方面未发现差异。在INSURE后72小时内需要机械通气的第2组早产儿在出生后1分钟和5分钟时的平均阿氏评分显著较低,出生复苏期间外周血氧饱和度(SpO2)也较低(p<0.05)。成功的INSURE策略与更大的GA、出生体重(BW)、复苏期间的吸入氧分数(FiO2)以及表面活性剂平均剂量增加有关,但这些关联无统计学意义(p>0.5)。

结论

在胎龄≤32周的早产儿中,INSURE失败率增加与复杂妊娠、出生后1分钟和5分钟时显著较低的阿氏评分以及复苏期间较低的外周血氧饱和度有关。